Chinese Hepatolgy ›› 2026, Vol. 31 ›› Issue (9): 1348-1354.

• Other Liver Diseases • Previous Articles     Next Articles

The expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue and their relationship with clinical pathological features and prognosis of patients

Li Qiang1, Li Ying2, Liu Xing1, Huang Yanjie1, Zhao Chen3, Dai Jianguo1   

  1. 1. Department of Hepatobiliary Pancreatic Surgery, Zhangjiakou First Hospital, Zhangjiakou 075000, China;
    2. Qiaodong District Hospital, Zhangjiakou 075000,China;
    3. Hebei Huaao Hospital, Zhangjiakou 075000, China
  • Received:2025-09-18 Online:2026-09-30 Published:2026-11-16
  • Contact: Liu Xing,Email: xuxkx34@163.com

Abstract: Objective To investigate the expression of 14-3-3θ and tissue inhibitor of metalloproteinase (TIMP) 3 in gallbladder cancer tissue and their relationship with clinical pathological features and prognosis of patients. Methods A total of 113 patients with gallbladder cancer admitted to Zhangjiakou First Hospital from March 2020 to June 2021 were regarded as the research subjects. Immunohistochemistry was applied to detect the expression of 14-3-3θ and TIMP3 in gallbladder cancer and its adjacent tissues. Kaplan-Meier curve was applied to analyze the relationship between the expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue and prognosis. Multivariate Cox regression was applied to analyze the factors influencing the prognosis of gallbladder cancer. Results Compared with adjacent tissues (32/113, 28.32%), the positive expression rate of 14-3-3θ (85/113, 75.22%) was higher in gallbladder cancer tissues (χ2=48.779, P<0.05), and the positive expression rate of TIMP3 (31/113, 27.43%) was lower (χ2=59.769, P<0.05). The expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue was related to differentiation degree (χ2=5.509, 6.023) and TNM staging (χ2=8.203, 7.636) (P<0.05). The three-year overall survival rate of 113 patients with gallbladder cancer was 51.33%. Compared with the survival group [19/58, 32.76%; 10/58, 17.24%; (61.62 ± 11.48) U/mL; (80.45 ± 13.16) U/mL], the proportions of low/undifferentiated (35/55, 63.64%) and TNM stage Ⅲ (27/55, 49.09%), as well as the levels of carbohydrate antigen (CA) -125 [(84.51 ± 13.95) U/mL] and CA 19-9 [(106.23 ± 16.37) U/mL] in the death group were significantly higher (P<0.05). Compared with the survival group (38/85, 44.71%), the death group had a higher positive expression rate of 14-3-3θ in gallbladder cancer tissue (47/85, 55.29%) (χ2=6.020, P<0.05), and a lower positive expression rate of TIMP3 (9/31, 29.03%) (χ2=6.596, P<0.05). Multivariate Cox regression analysis showed that The degree of differentiation (HR=1.846), TNM stage (HR=2.059), 14-3-3θ (HR=1.562), TIMP3 (HR=0.913), CA-125 (HR=1.781), and CA19-9 (HR=1.906) were related to the prognosis of gallbladder cancer (P<0.05). Kaplan-Meier analysis showed that the three-year overall survival rate (44.71%) of patients with 14-3-3θ positive expression was lower than that of patients with 14-3-3θ negative expression (71.43%) (Log Rank χ2=5.627, P=0.018). The three-year overall survival rate of TIMP3 positive expression patients (70.97%) was higher than that of TIMP3 negative expression patients (43.90%) (Log Rank χ2=6.130, P=0.013). Conclusion The positive expression rate of 14-3-3θ is higher in gallbladder cancer tissue, while the positive expression rate of TIMP3 is lower. The expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue is closely related to the clinical pathological features and prognosis of patients.

Key words: Gallbladder cancer, Clinical pathological features, Prognosis, 14-3-3θ, Tissue inhibitors of metalloproteinase 3